Insulin resistance in patients with type 2 diabetes or obesity leads to an increase in PAI-1 and high levels throughout the day compared to normal individuals, creating an environment of reduced fibrinolysis that promotes the development of cardiovascular complications. This evidence concerns the gene SERPINE1 and obesity due to melanocortin 4 receptor deficiency.